Invion Ltd. (AU:IVX) has released an update.
Invion Ltd., a life-science company listed on the ASX, has updated its timetable for a 100-to-1 capital consolidation, set to take effect in November 2024. This move is part of Invion’s broader strategy as it advances its innovative Photosoft technology for cancer treatment. Investors should note the key dates for trading adjustments and share register updates.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.
